Академический Документы
Профессиональный Документы
Культура Документы
CITATIONS
READS
139
2 authors, including:
Bilal Gondal
The University of Chicago M
27 PUBLICATIONS 68 CITATIONS
SEE PROFILE
MD, MRCSI,
Meghna C. Trivedi,
MD*
KEYWORDS
Stoma output Ileostomy Colostomy Management of stomas Nutrition support
High-output stoma
DEFINITIONS
High-Output Ostomy
a later date, allowing the blind loop of intestine to be used once again and, more importantly, eliminating the need for an ostomy, allowing the patient to defecate normally.
Types:
Gastrostomy and jejunostomy: openings between the abdominal wall and stomach or jejunum, respectively. These openings are used predominantly for enteral
feeding tubes.
Ileostomy: opening from the small intestine to the abdominal wall so that feces
bypass the large intestine and the anal canal.
Colostomy: opening from the large intestine to the abdominal wall so that feces
bypass the anal canal.
Urostomy: connection between the urinary tract and abdominal wall leading to a
urinary conduit so urine passes straight into a stoma bag and thus bypasses
the urethra.
2. What is the typical ostomy output/stool output in different types of resections?
Jejunostomy: A jejunostomy is a high-output fecal stoma and can have up to
6 L/d of stomal output. The jejunum is a major organ for nutrient absorption
(most fats, proteins, vitamins, and carbohydrates not already absorbed in the
stomach and duodenum).2 It is important to emphasize to patients that they
should limit the oral intake of fluids or a vicious cycle may begin. A jejunostomy
tube placed for feeding should be clamped when not in use, not left to drain.
Ileostomy: Initially 1200 mL/d which then decreases to about 600 mL/d. During
the early postoperative period and episodes of gastroenteritis, daily output can
be 1800 mL or even higher.3
Colostomy: 200 to 600 mL/d (Table 1).
3. What is a high-output stoma?
Normally in a healthy adult, about 4 L of intestinal secretions (0.5 L saliva, 2 L gastric
acid, and 1.5 L pancreaticobiliary secretions) are produced in response to food and
Table 1
Characteristics of different types of ostomies
Type of Ostomy
Location
Type of Discharge
Patient Problems
Ileostomy
Right lower
quadrant
Skin protection
Odorous
Dehydration
Food blockage
Ascending colostomy
Middle or right
upper abdomen
Liquid or semisolid
Contains digestive
enzymes
Skin protection
Odorous
Dehydration
Gas control
Transverse colostomy
Center of abdomen,
higher side
Semisolid
Frequent drainage
May contain
digestive enzymes
Skin protection
Odorous
Gas control
Descending colostomy
or sigmoid colostomy
Normal stool
Odorous
Skin protection
Odorous
Gas control
e543
e544
drink each day.4 A high-output stoma (HOS) is defined as greater than 2 L (8 cups) of
fluid from the ostomy in a 24-hour period.
STOMA COMPLICATIONS
Intra-abdominal sepsis
Surgery leaving less than 200 cm residual small bowel and no remaining colon
Obstruction in intestine at stoma site or proximal
Infection of the intestine (eg, Clostridium difficile). Methicillin-resistant Staphylococcus aureus enteritis is also reported to cause a high stoma output in the early
postoperative period after bowel surgery8
Active Crohn disease
Radiation enteritis
Withdrawal of medications, such as steroids or opiates
Administration of certain prokinetic medications (eg, metoclopramide, erythromycin, or laxatives). Metformin has also been shown to cause increased stomal
output9
High-Output Ostomy
to contain and may cause leakage. Patients may complain of dry mouth,
increased thirst, fatigue, light-headedness, shortness of breath, muscle cramps,
or abdominal cramping. It is important to evaluate these patients for signs of
dehydration and electrolyte disturbances. Hyponatremia, hypokalemia, and hypomagnesemia are commonly noted in these patients.10 Dehydration can lead
to renal failure.
HOS puts patients at risk of malnutrition. Patients complain of feeling fatigued or
dizzy; they may have unintentional weight loss, impaired wound healing (due to
protein-energy malnutrition and inadequate micronutrients), and easy bruisability
(due to vitamin deficiency or malabsorption).
3. What are the psychological effects of having a stoma?
Anxiety and depression are commonly seen; ostomies may contribute to perceived
reduced quality of life. It is crucial to prepare patients undergoing stoma formation
with educational materials and one-on-one counseling with a mental health specialist.
Introducing patients to other patients who already live with an ostomy may also be
valuable. The first few weeks post stoma are the most vital. Patients frequently have
difficulty managing their stoma while performing daily activities (eg, shopping), and
changing bags without necessary facilities. Patients may experience a change in
body image, and intimate relationships may suffer.11,12
Phantom rectum may occur during the first weeks after a colostomy or ileostomy,
whereby patients may experience sudden urges to defecate. In this case the patient
may require reassurance and support, as this can be very distressing.
MANAGEMENT
Patients should be linked with a nutrition counselor who has experience in managing
these complex patients. A multidisciplinary approach to management of HOS should
e545
e546
be undertaken. It should include the patient and his or her family, a nutritionist, the
patients surgeon, and potentially other health care providers.
High-Output Ostomy
e547
e548
Table 2
Dietary recommendations for patients with ostomy
Food
Reason
Prevents bloating
Helps digestion and absorption
Helps meet nutritional needs
High-Output Ostomy
increases intestinal and renal absorption of magnesium. The dose of 0.25 to 9 mg daily
is gradually increased (every 24 weeks in 0.25-mg increments) while ensuring that
hypercalcemia does not occur.27 Magnesium can also be administered in intravenous
infusions with saline.
PERFORMANCE IMPROVEMENT
Nightingale J, Woodward JM. Guidelines for the management of patients with a short
bowel; on behalf of the Small Bowel and Nutrition Committee of the British Society of
Gastroenterology. Published in Gut. Available at http://dx.doi.org/10.1136/gut.2006.
091108.
FUTURE DIRECTIONS
Four randomized placebo-controlled trials have been performed using growth hormone to stimulate mucosal growth for better absorption of nutrients.2830 In 3 studies
there was no significant increase in nutrient absorption, but 1 did show a small
improvement in nutrient absorption.31
GLP-2 has been shown to cause villus growth. Plasma levels of GLP-2 are low in
patients with jejunostomy.32 GLP-2 is given as subcutaneous injections, and a small
increase in nutrient absorption has been shown.33
Intestinal transplantations are possible in patients with intestinal failure, and more
than 1200 such surgeries have been performed worldwide. Intestinal transplant has
not yet been recommended as an alternative therapy for patients with intestinal failure
who have been safely maintained on long-term intravenous nutrition, which is partly
due to the excellent outcomes reported for long-term parenteral nutrition and the complications and challenges posed by intestinal transplant.34
REFERENCES
e549
e550
High-Output Ostomy
25. Goulston K, Harrison DD, Skyring AP. Effect of mineralocorticoids on the sodium/
potassium ratio of human ileostomy fluid. Lancet 1963;2:5413, 118.
26. Levitan R, Goulston K. Water and electrolyte content of human ileostomy fluid
after d-aldosterone administration. Gastroenterology 1967;52:5102.
27. Fukumoto S, Matsumoto T, Tanaka Y, et al. Renal magnesium wasting in a patient
with short bowel syndrome with magnesium deficiency: effect of 1 alphahydroxyvitamin D3 treatment. J Clin Endocrinol Metab 1987;65(6):13014.
28. Ellegard L, Bosaeus I, Nordgren S, et al. Low-dose recombinant human growth
hormone increases body weight and lean body mass in patients with short bowel
syndrome. Ann Surg 1997;225(1):8896.
29. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine,
and diet on adaptation in short-bowel syndrome: a randomized, controlled study.
Gastroenterology 1997;113:107481.
30. Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone
with glutamine and no change in diet on intestinal absorption in short bowel
patients: a randomised, double blind, crossover, placebo controlled study. Gut
2000;47(2):199205.
31. Seguy D, Vahedi K, Kapel N, et al. Low-dose growth hormone in adult home
parenteral nutrition-dependent short bowel syndrome patients: a positive study.
Gastroenterology 2003;124(2):293302.
32. Jeppesen PB, Hartmann B, Hansen BS, et al. Impaired meal stimulated
glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure. Gut 1999;45(4):55963.
33. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves
nutrient absorption and nutritional status in short-bowel patients with no colon.
Gastroenterology 2001;120(4):80615.
34. Woodward JM, Mayer D. Review: the unique challenge of small intestinal transplantation. Br J Hosp Med 1996;56(6):28590.
e551